This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Tella, Inc., Hokkaido University, Chugai Seiyaku Kabushiki Kaisha. Active years: 2012-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hokkaido, JP (2017)
- Sapporo, JP (2012 - 2019)
Company Filing History:
3 out of 4 
2 out of 443 
1 out of 991 
Years Active: 2012-2019
Title: The Innovative Contributions of Takashi Nishimura
Introduction
Takashi Nishimura, an accomplished inventor based in Sapporo, Japan, has made significant strides in the field of biotechnology. With a total of five patents to his name, he has focused on developing innovative solutions aimed at improving cancer therapies through immunological responses.
Latest Patents
One of Nishimura's latest developments is the creation of a novel WT1 antigenic polypeptide along with an anti-tumor agent that incorporates this polypeptide. The primary challenge addressed by this invention is to provide a polypeptide capable of stimulating a diverse array of T cells, thereby eliciting a robust immunological reaction against various forms of cancer. The solution presented involves a fused polypeptide that combines helper and killer epitopes derived from the WT1 protein, achieving a delicate balance of three to six epitopes per molecule for maximum effectiveness.
Additionally, another significant patent involves partial peptides of survivin. This invention aims to introduce a novel tumor antigen and a therapeutic agent for treating malignant neoplasms using this antigen. The disclosed polypeptide possesses an epitope that can activate Th1 cells, which are specific to Survivin, thereby promoting cytokine production in Th cells when exposed to antigen-presenting cells along with CD4-positive T cells.
Career Highlights
Throughout his career, Nishimura has collaborated with various esteemed institutions and companies. Notably, he has worked with Tella, Inc. and Hokkaido University, contributing to advancing cancer research and therapeutic interventions.
Collaborations
Among his distinguished coworkers are Masaki Yasukawa and Yuji Heike. Their collaborative efforts have fostered an environment of innovation and have been instrumental in his research endeavors, particularly in the biotech sector focusing on cancer treatment.
Conclusion
Takashi Nishimura emerges as a noteworthy inventor in the field of immunology and oncology, demonstrating a passion for addressing critical challenges in cancer therapy. His patents not only showcase his innovative thinking but also align with the broader goal of enhancing patient care through advanced medical solutions. As his career continues to evolve, he remains a key figure to watch in the realm of cancer research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile